Accuray Incorporated Common Stock (ARAY)
Stock · NASDAQ · Health Care
$0.1535as of 10/16/2026
Price chart
Active signals
ARAY Signal Track Record
How signals performed across all stocks →What ARAY's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Volume Spike | 37 | -1.3% | 43% | September 24, 2026 |
| Bollinger Band BreakdownActive now | 23 | +7.4% | 65% | July 27, 2026 |
| Bollinger Band Breakout | 22 | -5.4% | 32% | September 28, 2026 |
| 200-Day Moving Average TouchActive now | 7 | -6.8% | 14% | October 17, 2025 |
| Any 20-session window (baseline) | -1.7% | 44% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About ARAY
Accuray Incorporated engages in the design, development, and sale of radiosurgery and radiation therapy systems for the treatment of tumors throughout the body in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, and China. The company offers the CyberKnife platform, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used f…
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Employees
- 809
- Website
- www.accuray.com/
Fundamentals
- 1-day range
- $0.1534$0.1794
- Market cap
- $33.63M
- P/E (trailing)
- —
- P/E (forward)
- -0.65
- EPS (trailing)
- $-0.41
- Dividend yield
- —
- Beta
- 1.33
- Avg. volume
- 7.26M
How Accuray Incorporated Common Stock Makes Money
Where the revenue actually goes — FY2026 annual results
Source: 10-K filed Aug 27, 2026 · via SEC EDGAR / Finnhub
Forecasts
1 analyst ratings
Accuray Incorporated Common Stock Competitors
Chosen by industry and closest market cap.
- ARAYAccuray Incorporated Common Stock$0.16▼ 5.88%Market cap $33.63MP/E —$0.1615$1.86
- NSPRInspireMD Inc. Common Stock$0.46▼ 4.17%Market cap $33.87MP/E —$0.4604$2.54
- PAVMPAVmed Inc. Common Stock$2.41▼ 0.62%Market cap $35.93MP/E —$2.27$28.44
- TELATELA Bio Inc. Common Stock$0.975▼ 3.47%Market cap $38.50MP/E —$0.5011$1.56
- BEATHeartbeam Inc. Common Stock$0.436▲ 0.93%Market cap $28.33MP/E —$0.355$4
- NEPHNephros Inc. Common Stock$3.65▲ 3.99%Market cap $38.98MP/E 21.52$2.66$6.42
- CNSYCerenome Inc. Common Stock$1.7▼ 9.57%Market cap $26.57MP/E —$1.49$4.16
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| ARAY Accuray Incorporated Common Stock | $33.63M | — | $0.16 | ▼ 5.88% | $0.1615$1.86 |
| NSPR InspireMD Inc. Common Stock | $33.87M | — | $0.46 | ▼ 4.17% | $0.4604$2.54 |
| PAVM PAVmed Inc. Common Stock | $35.93M | — | $2.41 | ▼ 0.62% | $2.27$28.44 |
| TELA TELA Bio Inc. Common Stock | $38.50M | — | $0.975 | ▼ 3.47% | $0.5011$1.56 |
| BEAT Heartbeam Inc. Common Stock | $28.33M | — | $0.436 | ▲ 0.93% | $0.355$4 |
| NEPH Nephros Inc. Common Stock | $38.98M | 21.52 | $3.65 | ▲ 3.99% | $2.66$6.42 |
| CNSY Cerenome Inc. Common Stock | $26.57M | — | $1.7 | ▼ 9.57% | $1.49$4.16 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
- Accuray Announces Stockholder Approval of Key Financing-Related Proposals and Appointment of New Independent DirectorYahoo · 10/6/2026
- 12 Health Care Stocks Moving In Monday's After-Market SessionBenzinga · 10/5/2026
- 12 Health Care Stocks Moving In Friday's After-Market SessionBenzinga · 10/2/2026
- 12 Health Care Stocks Moving In Tuesday's After-Market SessionBenzinga · 9/29/2026
- 12 Health Care Stocks Moving In Tuesday's Pre-Market SessionBenzinga · 9/29/2026
- Top stock movements in today's session.ChartMill · 9/28/2026
- Check out the stocks that are attracting the most attention and driving market activity.ChartMill · 9/28/2026
- Let's take a look at the stocks that are in motion in today's session.ChartMill · 9/28/2026
Insider Activity
Insider Actions →- Richard A. Meier · October 5, 2026 · Grant75.0K
- Pervaiz Ali · September 23, 2026 · Tax Withholding8.9K @ $0.2255
- Pervaiz Ali · September 23, 2026 · Grant19.8K
- TCW GROUP INC · July 29, 2026 · J598.1K
- TCW GROUP INC · July 29, 2026 · J7.99M
- Miele Paul Michael · May 29, 2026 · Grant650.0K
- TCW GROUP INC · May 19, 2026 · J75.6K
- TCW GROUP INC · May 19, 2026 · J808.0K
- TCW GROUP INC · May 19, 2026 · J1.41M
- TCW GROUP INC · May 19, 2026 · J1.01M
- TCW GROUP INC · May 19, 2026 · J60.5K
- TCW GROUP INC · May 19, 2026 · J105.9K
Institutional Ownership
March 31, 2026
- Total shares held
- 74.20M
- Total value held
- $26.62M
- Institutional holders
- 122
- Unknown15.47M
- Unknown8.46M
- Unknown5.86M
- Unknown5.64M
- Unknown5.06M
- Unknown4.43M
- Unknown2.38M
- Unknown2.35M
- Unknown2.29M
- Unknown2.02M
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 30, 2026
Accuray (ARAY) noted among health‑care stocks moving in recent sessions
Accuray appeared in several recent lists of health‑care stocks showing price movement in pre‑market, after‑market and intraday sessions. The activity comes as the stock trades near its $0.25 support level with an RSI around 58, suggesting modest momentum. Analysts have an average target of $0.35, above the current price.
Accuray (ARAY) noted among health‑care stocks moving in recent sessions. Accuray appeared in several recent lists of health‑care stocks showing price movement in pre‑market, after‑market and intraday sessions. The activity comes as the stock trades near its $0.25 support level with an RSI around 58, suggesting modest momentum. Analysts have an average target of $0.35, above the current price.